Separate Worlds Set to Collide: Smallpox, Vaccinia Virus Vaccination, and Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome
Open Access
- 1 August 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (3) , 426-432
- https://doi.org/10.1086/375823
Abstract
Concerns about the possible release of smallpox by bioterrorists has led to policies that recommend smallpox vaccination of some health care providers, and, in the near future, the vaccine may become available to the general population on a voluntary basis. Both smallpox virus (variola virus) and the smallpox vaccine (vaccinia virus) will have a significant impact on people infected with human immunodeficiency virus (HIV). Given that populations with acquired immunodeficiency syndrome and populations with immunosuppressed conditions due to solid organ and bone marrow transplantation were not present in the days when smallpox was prevalent, we will speculate on how smallpox might present in immunodeficient patients, and we will review the adverse events expected from the smallpox vaccine in hosts with HIV infection.Keywords
This publication has 22 references indexed in Scilit:
- Smallpox Vaccination and Patients with Human Immunodeficiency Virus Infection or Acquired Immunodeficiency SyndromeClinical Infectious Diseases, 2003
- Developing New Smallpox VaccinesEmerging Infectious Diseases, 2001
- Cidofovir Protects Mice against Lethal Aerosol or Intranasal Cowpox Virus ChallengeThe Journal of Infectious Diseases, 2000
- Anti-HIV cellular immunotherapy in AIDSThe Lancet, 1991
- Prevention of vaccinia virus infection in imiminodeficient mice by vector-directed IL-2 expressionNature, 1987
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseNew England Journal of Medicine, 1987
- Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defectThe Journal of Pediatrics, 1978
- Variola Major in West PakistanThe Journal of Infectious Diseases, 1970
- Vaccinia Gangrenosa with Normal Humoral Antibodies A Case Possibly Due to Deficient Cellular Immunity Treated with N‐Methylisatin β‐Thiosemicarbazone (Compound 33T57, Marboran)Acta Paediatrica, 1966
- PROPHYLACTIC TREATMENT OF SMALLPOX CONTACTS WITH N-METHYLISATIN β-THIOSEMICARBAZONE (COMPOUND 33T57, MARBORAN)The Lancet, 1963